海外市场拓展
Search documents
三星医疗:公司对欧洲市场的销售方式包含境内主体直接向欧洲客户出口
Zheng Quan Ri Bao Wang· 2026-01-16 15:12
Group 1 - The company has two production bases in Europe located in Poland and Germany [1] - A new sales company in Hungary is expected to be established in the first half of 2025 [1] - The company's sales strategy in Europe includes direct exports to European customers and sales through subsidiaries established in Europe [1]
澳华内镜:公司近年存在向欧盟成员国出口及销售相关业务
Zheng Quan Ri Bao· 2026-01-16 12:17
(文章来源:证券日报) 证券日报网讯 1月16日,澳华内镜在互动平台回答投资者提问时表示,公司近年存在向欧盟成员国出口 及销售相关业务,多款核心产品已取得欧盟市场准入资质并实现销售;关于欧盟地区业务收入在公司整 体营业收入中的具体占比,请以公司对外披露信息为准;公司对欧盟市场的销售采用多元化模式推进, 一方面通过2018年收购的慕尼黑子公司WISAP开展当地的营销、销售及服务工作,另一方面也借助第 三方贸易商、代理商的渠道资源进行转销,以进一步拓宽市场覆盖范围,未来公司将持续深耕包括欧盟 在内的海外市场,相关业务进展敬请关注公司后续公开信息披露。 ...
友发集团:公司近年通过第三方贸易商向欧盟市场进行出口钢管约数万吨
Zheng Quan Ri Bao Wang· 2026-01-16 11:41
Core Viewpoint - The company is actively expanding its overseas operations, particularly in the EU market, through direct export trade and overseas capacity layout, while maintaining a focus on sustainable development and market competitiveness [1] Group 1: Export Activities - The company has exported approximately tens of thousands of tons of steel pipes to the EU market in recent years, which constitutes a small proportion of its overall revenue [1] - Key export destinations include Germany, Greece, the Netherlands, and Belgium [1] Group 2: Overseas Expansion - The company has established subsidiaries, "Tianjin Youfa International Trade Co., Ltd." and "Youfa (Hainan) International Trade Co., Ltd." to develop direct export trade [1] - The company is also investing in trade and production projects through "Tianjin Youfa International Pipe Industry Co., Ltd." to enhance its international trade capabilities [1] Group 3: Strategic Goals - The company promotes industrial cooperation and green development, aiming to lead the industry towards healthy and sustainable growth [1] - The company is focused on increasing its market share and brand influence, showcasing a competitive advantage in both domestic and international markets [1] - The ultimate goal is to achieve global development for Youfa steel pipes [1]
联建光电:公司目前在荷兰、美国、日本等地区设有办事处并提供相应本地化服务
Zheng Quan Ri Bao· 2026-01-16 10:15
Core Viewpoint - The company is focused on expanding its global presence in the LED display solutions market, emphasizing local partnerships and tailored products to meet regional demands [2] Group 1: Global Market Strategy - The company has established offices in the Netherlands, the United States, and Japan, providing localized services to enhance customer support [2] - The market operations cover Europe, the Americas, Asia-Pacific, and the Middle East, indicating a broad international reach [2] - Future plans include a steady advancement of the 2026 strategy, with specific country expansions based on market research and business planning [2] Group 2: Strategic Partnerships - The company prioritizes building and deepening strategic partnerships with local excellent partners to leverage combined resources [2] - The goal is to co-develop products and customized solutions that are closely aligned with local market needs [2] - The company aims for mutual benefits with partners to drive sustainable and high-quality growth in international markets [2]
科华生物:公司2025年半年度海外营业收入为228042894.49元
Zheng Quan Ri Bao Zhi Sheng· 2026-01-16 10:04
证券日报网讯 1月16日,科华生物在互动平台回答投资者提问时表示,公司业务发展立足中国、布局全 球,经过在体外诊断行业40余年积累,产品已出口至海外100多个国家和地区。公司积极拓展海外市 场,一方面借助意大利子公司TGS在欧洲地区的销售网络优势进一步拓展欧洲市场。同时,公司在海外 多个国家逐步建立本地服务体系,深入荷兰、韩国、哈萨克斯坦、泰国、越南、斯里兰卡、巴基斯坦、 缅甸、秘鲁等国家进行商业布局,完成诊断仪器及试剂的产品注册并销售。根据公司于2025年8月27日 披露的《2025年半年度报告》,公司2025年半年度海外营业收入为228042894.49元,同比增长20.16%。 (编辑 袁冠琳) ...
赛科希德:近两年有出口欧盟业务但销售额较小,国际市场主要采取经销模式
Jin Rong Jie· 2026-01-16 09:28
声明:市场有风险,投资需谨慎。本文为AI基于第三方数据生成,仅供参考,不构成个人投资建议。 本文源自:市场资讯 作者:公告君 有投资者在互动平台向赛科希德提问:"请问公司近年是否存在向欧盟成员国出口或销售的相关业务? 如有,欧盟地区业务收入在公司整体营业收入中的占比大致为多少?此外,公司对欧盟市场的销售主要 通过哪种方式实现:是以境内主体直接向欧盟客户出口为主,还是通过在欧盟国家设立的子公司进行销 售,或通过第三方贸易商、代理商转销至欧盟市场?" 针对上述提问,赛科希德回应称:"尊敬的投资者,公司近两年有出口欧盟国家的业务,但销售额较 小,在整体业务中占比较低。公司目前在国际市场上的销售模式主要采取经销模式。公司高度重视海外 业务发展,将继续努力拓展国际市场业务。感谢您对公司业务的关注。" ...
药康生物:公司已组建约40人海外BD团队,覆盖北美、欧洲及亚太三大区域,在超20个国家实现销售
Mei Ri Jing Ji Xin Wen· 2026-01-16 08:51
(文章来源:每日经济新闻) 药康生物(688046.SH)1月16日在投资者互动平台表示,公司已组建约40人海外BD团队,覆盖北美、 欧洲及亚太三大区域,在超20个国家实现销售。公司在欧洲区域设有办公室,以直销为主,覆盖德国、 英国、法国、瑞士、意大利等国家,2025年欧洲区域增长良好,市场渗透率持续提升。具体财务数据请 关注公司相关公告。 每经AI快讯,有投资者在投资者互动平台提问:请问公司近年是否存在向欧盟出口或销售的相关业 务?如有,欧盟地区业务收入在公司整体营业收入中的占比大致为多少?此外,公司对欧盟市场的销售 主要通过哪种方式实现?是以境内主体直接向欧盟客户出口为主,还是通过在欧盟国家设立的子公司进 行销售,或通过第三方贸易商、代理商转销至欧盟市场? ...
港股异动 | 安东油田服务(03337)涨超13% 公司深耕伊拉克市场 未来将大力拓展中东其他地区
智通财经网· 2026-01-16 07:40
Group 1 - Antong Oilfield Services (03337) saw a stock increase of over 13%, trading at 0.9 HKD with a transaction volume of 18.8468 million HKD [1] - Goldman Sachs reported that Brent crude oil has risen nearly 6 USD to over 66 USD per barrel, reflecting market expectations of a potential supply disruption of 700,000 barrels per day from Iran over the next 12 months [1] - Global Fortune previously indicated that since 2025, Iraq is expected to experience a wave of Western energy companies returning, with Antong Oilfield Services deeply engaged in the Iraqi market, having secured a 25-year oilfield development contract [1] Group 2 - The company is expected to continue its focus on the Iraqi market, actively seizing opportunities for oil and gas production increases, and accelerating the implementation of new projects [1] - Antong Oilfield Services plans to expand its presence in other overseas markets, including the Middle East, Africa, and Southeast Asia [1]
山东墨龙:公司产品广泛用于石油、天然气、页岩气等领域
Zheng Quan Ri Bao Wang· 2026-01-16 01:47
Core Viewpoint - Shandong Molong's products are widely used in various sectors including oil, natural gas, shale gas, coalbed methane, hydrogen energy, petroleum refining, engineering machinery manufacturing, and oilfield services, showcasing a strong market presence and competitive edge in both domestic and international markets [1] Group 1 - The company has a diverse customer base that includes major domestic oil groups such as China National Petroleum Corporation, Sinopec, CNOOC, and Yanchang Petroleum Group, as well as oilfields in over 50 countries across Asia, Europe, America, Africa, and Oceania [1] - The company reported a sufficient order backlog, indicating successful outcomes in production operations, market expansion, equipment upgrades, product research and development, and key projects [1] - In November 2025, the company participated in the Abu Dhabi International Petroleum Exhibition (ADIPEC) and successfully signed product orders exceeding 40,000 tons in Middle Eastern countries, marking a significant achievement in overseas market expansion [1] Group 2 - The continuous growth in overseas orders demonstrates Shandong Molong's strong competitiveness in the international market, providing robust support and assurance for the company's rapid development in the future [1]
海外业务快速增长 楚天科技2025年预计盈利2.35亿元到3亿元
Zheng Quan Shi Bao Wang· 2026-01-16 01:29
Core Viewpoint - Chutian Technology (300358) is expected to return to profit growth in 2025, with projected net profit ranging from 235 million to 300 million yuan, following a loss of 453 million yuan in the previous year [1] Group 1: Financial Performance - The company anticipates a net profit of 135 million to 200 million yuan after excluding non-recurring gains and losses for 2025 [1] - For the first three quarters, Chutian Technology reported operating revenue of 3.896 billion yuan and a net profit attributable to shareholders of 84.46 million yuan, estimating a fourth-quarter net profit of 151 million to 215 million yuan [1] Group 2: Growth Drivers - The growth in performance is attributed to international market expansion, improved order quality, and cost reduction measures [1][2] - The company has seen a significant increase in the quality and gross margin of new order contracts during the reporting period [1] - Non-recurring gains and losses are expected to impact the 2025 net profit by approximately 100 million yuan [1] Group 3: International Market Expansion - Chutian Technology is intensifying its efforts in international market expansion, achieving breakthroughs in Southeast Asia, the Middle East, Africa, and the Americas, leading to a significant increase in the proportion of international business [1][2] - The company has segmented the global market into five regions to enhance local sales and service responsiveness [2] Group 4: Operational Strategies - Starting from the second half of 2024, the company will implement a differentiated competition strategy to enhance order quality and has initiated various cost reduction measures [2] - The company is optimizing product solutions in R&D, reducing procurement costs in the supply chain, and improving production efficiency, which has led to a noticeable increase in gross margin [2] - A series of refined management measures have been implemented to control overall operating costs, with total expenses significantly reduced compared to the previous year [2] Group 5: Future Outlook - Chutian Technology plans to continue expanding its overseas market presence while capitalizing on the growth and high-end transformation trends in the domestic pharmaceutical equipment industry [3] - The company aims to enhance the proportion of international business in its revenue and build a global high-end pharmaceutical equipment brand through innovation and product refinement [3]